ChromaDex reports new study on nicotinamide riboside importance
ChromaDex announced results of a preclinical study conducted by Nestle published last month in the journal Nature Communications, a peer-reviewed open access scientific journal published by the Nature Publishing Group. The study investigated the impact on the liver when its cells lose the ability to use the nutrient nicotinamide riboside, or NR. The preclinical study concluded that the tissue's natural ability to utilize NR is important for maintaining resilience during periods of metabolic stress such as a high-fat diet. It is also the first study to show the physiological consequences that arise when cells lose the ability to use NR. In December 2018, ChromaDex entered into a license and supply agreement for Niagen, or nicotinamide riboside, with Nestle Health Science. The body uses NR to boost nicotinamide adenine dinucleotide, or NAD, a molecule found in cells that powers metabolism and helps cells be more resilient in the face of metabolic stress.